Harbinger Health logo

Harbinger Health

Recent Finacing

Series B

Recent Raise

$140M


Harbinger Health is a biotechnology company that is developing a blood-based cancer screening product, utilizing machine learning and proprietary insights into cancer biology, with the aim to make cancer screening globally accessible, affordable, and reduce false positives.

Total Funding

$190M

Headquarters

Cambridge, USA

Founded

2020

Focus Areas

Biotechnology
Cancer Screening
Machine Learning

Investors

Flagship Pioneering logo
M&G logo
Pictet logo
Partners Investment logo